We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA’s Human Medicines Committee Recommends Two New Drugs
EMA’s Human Medicines Committee Recommends Two New Drugs
The European Medicines Agency’s (EMA) human medicines committee recommended two new drugs for approval at its monthly meeting last week, including a Sanofi biologic for a rare disorder and a generic of Novartis’ oncology drug Glivac (imatinib).